Meeting Report: Tumor Biology--How Signaling Processes Translate to Therapy
Karlheinz Friedrich1,
Ottmar Janssen2, and
Ralf Hass3*
1Institute of Biochemistry, Friedrich-Schiller University, 07743 Jena, Germany.
2Institute of Immunology, Christian-Albrechts University, 24105 Kiel, Germany.
3Biochemistry and Tumor Biology, Medical School, 30625 Hannover, Germany.
A report on the "Signal Transduction Society (STS) Meeting 2006: Signal Transduction-Receptors, Mediators and Genes," Weimar, Germany, 2 to 4 November 2006.
Abstract:
On the occasion of the 10th Joint Meeting "Signal Transduction—Receptors, Mediators and Genes" in November 2006, the Signal Transduction Society (STS) focused on the holy grail of translational research, that is, how basic signaling research might be transferred into cancer therapy. Participants heard of blockbusters and setbacks and learned of new therapeutic approaches that concentrate on distinct signaling pathways at a more individual level. Thus, the young STS community and the 300 meeting participants left with an optimistic outlook and the notion that the translational task will keep scientists busy all over the world for a while.
*Corresponding author: E-mail, hass.ralf{at}mh-hannover.de
